Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-19-049538

EVP, Strategy & Innovation acquired 6,172 shares (option exercise)

  • EVP, Strategy & Innovation gave up 1,868 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

ROBIN SHERRINGTON · EVP, Strategy & Innovation

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-09-12 Exercise or conversion : show line 1 in the form +6,172 $3.07 $18,948 12,064 D
2019-09-12 Shares withheld for taxes : show line 2 in the form −1,868 $9.38 $17,522 10,196 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-09-12 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −6,172 0 D
Loading xslF345X03/doc4.xml…